glp-1 drugs ozempic Semaglutide Like Wegovy, Have Weight-Loss Benefits — and Could Change the Economy GLP1 pills vs. injections: Which

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has today approved a new indication for Wegovy (semaglutide) to reduce the risk of overweight and obese adults suffering serious heart problems or strokes.

Here's what clinicians should know.

Underwriters are treating your clients' dramatic weight loss as a red flag, not a health victory

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective anti-glycemic and weight-loss medications with a strong safety record

Limited evidence suggests that combined SGLT2is/GLP1-RAs therapy can potentially improve most but not all outcomes

Safe, drug-free, non-GMO, USA-made